Meet the IP Professional: Nathaniel Taylor, Director and Patent Attorney at Keltie
Nathaniel Taylor has built his IP career around solving complex challenges in fast-moving sectors. These include electric vehicles, smart agriculture, and renewable energy systems. As a Director at Keltie and a Chartered and European Patent Attorney, he works closely with clients of all sizes. From high-growth startups to household names, he helps translate engineering ingenuity into strong, strategic IP portfolios.
We spoke to Nathaniel for our Meet the IP Professional series to explore the emerging tech he’s helping protect — and why good IP advice can be the catalyst for growth, agility, and long-term success.
From Engineering Student to IP Strategist
Nathaniel Taylor first encountered intellectual property during an engineering degree project focused on automating parcel-handling systems for Royal Mail. A visiting patent attorney explained how their solutions could be registered and licensed — a lightbulb moment that stuck.
“I realised I was really drawn to the conceptual and problem-solving aspects of engineering, rather than hands-on prototyping and manufacturing,” Nathaniel says. “A traditional engineering career would quickly become detached from any deep technical engagement, while IP offered a way to really stay connected to the core breakthrough technologies.”
That experience laid the foundations for a career focused on guiding innovative technologies through the patent process.
Driving Innovation in the Auto Sector
Nathaniel has worked on the electrification of vehicles at Jaguar Land Rover, which came at a key moment in the industry’s evolution. As the company developed new electric vehicle platforms, he was seconded to their team to harvest inventions and help draft a raft of patent applications directed to motor control systems for off-road performance.
“We were helping protect not just the tech, but the brand identity — preserving what makes JLR distinctive as they transitioned to electric platforms,” he explains.
His work for other automotive clients has included more speculative technologies, such as hydrogen propulsion systems. He helped clients draft patent applications with broad applicability, beyond hydrogen combustion applications, to retain utility even if the commercial interest in the hydrogen applications fell away. In emerging fields like climate tech, where innovation is fast-paced and outcomes are uncertain, he believes IP isn’t just about protection—it’s really about creating options and resilience.
Agri-Tech and the Power of a Strong Patent Portfolio
In the agricultural space, Nathaniel sees IP as a critical asset — particularly for startups navigating acquisition or scale-up. With automation and sensor-driven decision-making transforming farming, many smaller, tech-first firms are attracting interest from legacy players.
“Often, acquisitions are driven not just by talent and know-how, but by the underlying IP that provides a moat against competitive threats. A strong IP portfolio is what gives these companies leverage in negotiations,” Nathaniel says.
His focus is on helping these businesses secure practical protection while also positioning them for future funding and growth.
IP in the Age of Energy Flexibility
Renewable energy is one of the fastest-evolving sectors Nathaniel works in — and staying up to speed is essential. He regularly participates in innovation forums, founder communities, and sector events like London Climate Action Week to understand both technical developments and commercial realities.
One standout trend is the emergence of a diversified energy market that provides a greater variety of financing options for grid ancillary services. There are huge opportunities for companies to innovate and unlock new market opportunities, particularly with AI driving demand for electricity and data processing, Nathaniel expects a surge in IP activity in these areas over the coming years.
“These trends create whole new product categories. And that means opportunities for highly valuable IP.”
Supporting Startups with Practical IP Strategy
Nathaniel works closely with climate tech startups, many of which are navigating early-stage funding challenges and lack deep IP experience. At Keltie, he’s helped build support programmes tailored to these innovators. These include discounted initial services, educational resources, and pro bono partnerships with major law firms.
“We want founders to be empowered, not intimidated. IP isn’t just protection — it’s a growth tool.”
He also notes that the first patent application often serves as a key storytelling tool — something investors will review closely. That’s why clarity, technical accuracy, and commercial alignment all matter when drafting early filings.
Building IP That Can Pivot
Nathaniel believes flexibility is vital — especially for companies working with emerging or speculative technologies. He drafts patent applications with broader applicability, allowing clients to pivot to new sectors or adjacent markets without losing IP coverage.
“Your invention today might not be your business model tomorrow. We try to make sure the IP can evolve with you.”
That approach also helps with long-term licensing and commercial partnerships, where adaptable patent claims can open unexpected opportunities.
Filing with Global Vision
As both a Chartered and European Patent Attorney, Nathaniel brings a wide lens to global IP strategy. The European Patent Office has some of the strictest requirements — particularly around added matter — so he’s well-practised at drafting applications with foresight and jurisdiction-specific nuances.
“We’re always thinking ahead — how will this stand up in the US, UK, or Asia? And how might it need to evolve?”
He also highlights the UK’s 12-month fee-free period as an ideal first filing route for startups looking to make a low-cost but strategic move early on. Meanwhile, understanding key tools like the US grace period helps ensure clients are protected internationally.
What’s Next for IP in Emerging Tech?
Nathaniel sees several areas primed for rapid IP growth over the next 5–10 years:
Grid infrastructure and localised energy supply: IP filings in this space are expected to rise sharply as demand from AI and data centres grows.
Autonomous driving: With telecoms entering the automotive space, expect more IP disputes — but also more licensing and collaboration.
Data-driven agriculture: Large-scale sensor networks and precision farming will drive innovation — and require solid IP foundations.
Each of these trends reflects a broader shift: the convergence of traditional industries with new technologies and new players.
Life Outside the Office
When he’s not drafting claims or reviewing specs, Nathaniel enjoys golf, football, and a surprising new hobby: pottery, inspired by The Great Pottery Throwdown.
“I bought an electric spinning wheel online — slightly questionable wiring, but it’s working so far!”
He also recommends a walk along Bondi Beach in Sydney for stunning views, or a countryside ramble through King’s Langley farmland to the Cart and Horses pub — a personal favourite when visiting his family.
Final Thought: Build IP That Can Pivot With You
Nathaniel’s advice for startups and innovators? Successful IP strategy comes down to clarity, foresight, and agility. This is especially important in emerging sectors where commercial direction can shift rapidly.
“The most successful innovators are the ones prepared to pivot. We help ensure their IP can pivot with them.”
When Lawrence Cullen discusses Supplementary Protection Certificates (SPCs[i]), he does so with the clarity and passion of someone who has spent decades at the heart of the system—and who still finds it intellectually rewarding. After a distinguished career at the UK Intellectual Property Office (UKIPO), where he became one of the UK’s leading experts on SPCs, Lawrence has launched a consultancy to help others navigate the intricacies of life sciences IP.
From Chemistry Labs to IP Policy
Lawrence’s journey into IP began in the lab. Originally from Ireland, he studied industrial chemistry there at the University of Limerick. He then went on to complete a PhD at the University of Sheffield. A research career followed, taking him to UK. France, Germany, and the United States. It was during this time—working on a some patents at the University of Kentucky—that his interest in IP was sparked.
“I read my original proposal to the university for the patent and then saw the final patent application,” he recalls. “They were both describing the same thing but in completely different ways. I found that transformation fascinating.”
After returning to the UK with a young family and looking for a more stable career path, Lawrence applied to the UKIPO—and never looked back.
Building a Reputation in SPCs
Lawrence spent just under three decades at the UKIPO. Initially as a patent examiner, then working in policy and trademarks en route to becoming a Deputy Director and Hearing Officer in patents. His experience spans petrochemicals, cosmetics. pharmaceuticals and biotech, but it’s his specialism in SPCs that has become his hallmark.
“What makes SPCs so challenging is that they sit at the intersection of patent law and regulatory law,” he explains. “They’re not just a patent extension. They’re a sui generis right—unique in legal terms—and require a good understanding of both systems.”
As a Hearing Officer, Lawrence was responsible for reviewing disputed SPC applications. He often found himself deciding issues involving the UK’s approach to SPC case law for the first time. His decisions, nearly all of which were appealed (and subsequently upheld) helped clarify regulatory grey areas and provided vital guidance in a field where every word of the relevant legislation is scrutinised.
“It is not surprising that these decisions were nearly always appealed” he says “given the commercial value of the right being sought. Aa single granted SPC could be worth millions. That’s why nearly every one of the 19 articles in the relevant regulation has been argued over and litigated!”
A New Consultancy for a Complex Landscape
Now, Lawrence is offering his specialist knowledge directly to clients through his new consultancy. His goal? To support life sciences businesses, patent attorneys, and legal teams as they deal with complex SPC and pharmaceutical patent issues.
“If someone comes to me and asks, ‘Can I get an SPC based on this patent and this marketing authorisation?’ I can help them assess the options—perhaps even identify strategies they hadn’t considered.”
His expertise is particularly valuable at critical decision points: choosing the right patent to base an SPC on, assessing post-grant amendment possibilities, and anticipating how a granting authority might interpret a borderline case.
“Most people only apply for one SPC in a given matter, so there’s a lot riding on getting it right,” he adds. “My job is to bring clarity and reduce uncertainty.”
Beyond the Patent Office
Lawrence’s consultancy work is already expanding. He supports clients with early-stage planning, responds to refusals, and even helps those opposing SPCs in competitive scenarios. He’s also involved in academic research as a Visiting Scholar at the University of Sheffield, exploring the foundations and future of the SPC system.
His aim is to ensure that clients not only understand how the system works today but are also prepared for the changes ahead.
“We’re entering a more complex regulatory environment—particularly with medical devices and software becoming integral to treatments. That’s going to create new questions around if and how SPCs apply.”
Still Curious, Still Learning
Despite decades in the field, Lawrence’s enthusiasm remains undimmed.
“Every problem is slightly different. I still enjoy the ambiguity. You’re often working on the balance of probabilities, not certainties. That keeps it fresh.”
That curiosity extends beyond the office. When not immersed in SPC regulations, Lawrence is likely to be out walking stretches of the Wales Coast Path. Or, cheering from the stands at rugby games. A recent trip to Australia for the British & Irish Lions tour being a particular highlight.
“Being there and seeing the games in person was incredible. I’ve played the game, coached it, and still find it endlessly fascinating.”
How Lawrence Can Help
If you’re navigating SPCs—whether preparing an application, managing a refusal, or just trying to understand your strategic options—Lawrence is ready to help. With in-dept knowledge of how decisions are made and why, his consultancy offers a rare depth of insight for those operating in the life sciences, pharmaceutical, and biotech sectors. To get in touch with Lawrence or learn more about his services, connect via LinkedIn
A Supplementary Protection Certificate (SPC) is an intellectual property right that extends the protection of a patented active ingredient in a pharmaceutical or plant protection product. SPCs compensate for the time it takes to obtain regulatory approval before a product can be sold, offering up to five additional years of market exclusivity after a patent expires. Because they sit at the intersection of patent and regulatory law, SPCs are both legally and commercially significant—yet often misunderstood. This article explores their impact and the unique expertise Lawrence Cullen brings to this space.
Some careers are forged by ambition. Others by curiosity. For Joeeta Murphy, it was both. A former research scientist turned top-tier patent attorney, Joeeta blends a deep love of science with a sharp legal mind—bringing decades of insight to the ever-evolving world of life sciences intellectual property.
Now Head of Life Sciences at ip21, Joeeta’s career spans more than 30 years and reflects her unique ability to bridge two complex worlds: cutting-edge science and rigorous intellectual property strategy.
A Scientist at Heart, A Strategist by Choice
Joeeta began her career working on vaccines, diabetes, and Alzheimer’s research. But it was a law A-Level—taken in the evening out of sheer interest—that set her on a new path. “I didn’t want to give up science, but I also really enjoyed the legal side,” she explains. “Becoming a patent attorney allowed me to do both.”
That instinct paid off. Joeeta went on to complete an MSc in IP Management at Queen Mary, London, and qualified as a UK and European Patent Attorney. She now also holds the CIPA Litigation Certificate and is registered to represent clients before the Unified Patent Court (UPC).
But ask her which qualification was the toughest? “Definitely my MPhil in pharmaceutical sciences. It was a pure research degree—I was on my own, designing experiments and trying to make discoveries. That experience gave me huge respect for inventors. It’s what they do every day.”
The Power of Perspective
That scientific empathy has shaped Joeeta’s entire career. Whether advising startups or representing multinationals in high-stakes oppositions, she takes a tailored approach—always grounded in clarity, context, and commercial awareness.
“With startups, the focus is on budget and timing. We work closely to prioritise their innovations, patent filings and avoid early disclosure,” she explains. “With multinationals, it’s about building expansive, global patent portfolios and aligning with long-term product lifecycles.”
It’s a skillset that’s earned her a place on the IAM Strategy 300 list, for the third year running, recognising the world’s leading IP strategists.
A Career Highlight: Uncovering Hidden Value
Among her many successes, one case stands out. After reviewing a client’s large patent portfolio following an acquisition, Joeeta identified a buried platform patent with huge potential. “Several competitors were already in clinical trials using that technology—it was a clear case of infringement.”
Her work led to successful EPO oppositions, strategic pre-litigation moves, and ultimately a lucrative licensing deal for the client. “It was high pressure but incredibly rewarding. That’s when the job is really fun.”
Vision, Leadership and a Global Outlook
As head of ip21’s Life Sciences team, Joeeta combines legal excellence with natural leadership. “It all comes down to organisation and understanding priorities,” she says. She actively mentors young innovators through initiatives like the Trinity Bradfield Prize, and sits on the CIPA Council, helping shape the profession’s future.
For her, the best IP strategies are deeply embedded in a company’s broader goals. “Your IP should evolve with your business—identifying what to protect, where, and why. Freedom to operate and patentability searches are vital. So is knowing when to prune a portfolio.”
She’s also a passionate advocate for staying up to date. “Technology is always moving—so we have to move with it. That means reading constantly, attending conferences, and learning from our clients, who are often the real subject-matter experts.”
Life Outside IP: Snorkels, Spices and Cambridgeshire Walks
When she’s not in the courtroom or mentoring PhD students, Joeeta unwinds with cooking, countryside walks, and the occasional snorkelling adventure. “I’ve tried windsurfing—failed miserably,” she laughs. “But snorkelling in the Red Sea and in Key West, Florida was incredible.”
Her favourite recipe? A Bengali classic: chilli chicken, rich with spices and colour. “I love cooking with my children. They’ve picked up my tips and cook on their own now, which is brilliant.”
As for her go-to walk? “Around the Wimpole Estate in Cambridgeshire. It’s beautiful, and not too steep,” she says, smiling. “We also love visiting the Lake District and enjoy the circular walks and mountain scenery.”
A Lasting Legacy
Looking ahead, Joeeta is optimistic. “AI will transform drug discovery. Biotech innovation continues to accelerate. I want our Life Sciences team at ip21 to be at the forefront—offering the kind of support that makes a real difference to our clients’ success.”
And with Joeeta leading the way, there’s no doubt they will be.
Connect with Joeeta
If you’d like to follow more of Joeeta’s work or connect professionally, you can find her on LinkedIn. To explore the innovative IP services offered by her team, visit ip21 Ltd—a firm at the forefront of life sciences and biotech intellectual property.
PS: PatWorld works closely with leading Patent Attorneys like Joeeta Murphy to provide professional, reliable patent search services—including Freedom to Operate (FTO), Patentability, and Collection (State-of-the-Art) searches. Learn more.
Artificial intelligence is one of the fastest-moving areas of technology — and one of the hardest to search. New terms appear quickly, technologies overlap across industries, and relevant prior art can be described in ways that aren’t always obvious. This means that finding the right material isn’t just about using the latest search tools. It’s about knowing where to look, what to look for, and how to adapt as the field evolves.
Our team has over 200 years of combined searching experience across a wide range of technical fields. We’ve seen AI grow from early rule-based systems to today’s machine learning and generative AI. We’ve learned how patent offices, inventors, and technical authors describe these developments. Over time, we’ve built up a practical knowledge base of how AI shows up in prior art. Including the terms, variations, and classifications that can make all the difference in finding a key document.
We’ve also developed our own proven search methodologies for AI-related prior art. These combine carefully chosen keywords with specific patent classifications, refined through running hundreds of AI-related searches for patentability, invalidity, freedom to operate (FTO), and state-of-the-art projects. This approach helps us find relevant prior art that off-the-shelf searches can easily miss.
AI search tools are part of our process, and they can be powerful — but they work best in skilled hands. Our experience allows us to guide the tools, validate the results, and ensure the search is thorough and reliable.
In a field that changes almost daily, our combination of technology and hard-earned expertise gives our clients confidence that their AI prior art searches are both comprehensive and dependable.
Take the Next Step with PatWorld
Ready to secure your innovations and gain a competitive edge? PatWorld is here to assist you every step of the way. With our in-depth knowledge and industry-specific expertise, we provide the support you need to protect your intellectual property effectively.
Don’t wait to safeguard your innovations. Explore our Search Options orRequest a Quote today and take the first step towards comprehensive patent protection.
In the latest instalment of our Meet the IP Professional series, we spoke to Oliver Tidman, an Intellectual Property lawyer with a deep passion for brand protection and founder of Edinburgh-based law firm Tidman Legal. With a client-focused approach and a reputation for making IP law accessible, Oliver shared his journey into the world of trademarks, the challenges facing modern businesses, and why prevention truly is better than cure when it comes to protecting your brand.
A Natural Fit for Innovation and Identity
From early on in his legal career, Oliver was drawn to the intersection of law, innovation, and branding.
“I’ve always had an interest in the creative and commercial aspects of business and entrepreneurship — how ideas become valuable assets,” he explains. “Trademarks stood out because they’re so closely tied to a business’s identity and reputation. Helping people protect what makes their business unique felt like a natural fit.”
This focus on identity and growth led Oliver to establish Tidman Legal in 2017. Before founding his firm, he built experience both in private practice and in-house roles in Edinburgh and London, gaining valuable insights into how different organizations approach IP strategy.
Building a Client-Centred IP Practice
Tidman Legal has carved out a strong niche by offering clear, commercially-minded advice without unnecessary complexity. Whether supporting a startup registering its first trademark or guiding a business expanding overseas, Oliver and his team focus on aligning IP protection with long-term growth goals.
“We don’t just file trademarks—we help clients build IP strategies across trademarks, patents, designs and copyright. Everything is tailored to help move the business forward.”
Common Pitfalls and the Power of Early Action
When asked about the most frequent mistakes he sees among startups and SMEs, Oliver doesn’t hesitate:
“The biggest one? Launching a brand without properly checking if the name is available. Too often, businesses invest in branding, websites, and marketing—only to face opposition or be forced into a costly rebrand.”
To help businesses avoid this, Tidman Legal offers a free downloadable guide: “5 Pitfalls of Failing to Register a Trade Mark”5 Branding Pitfalls Guide.
He also stresses the importance of thinking globally from day one, especially for online businesses.
Navigating Disputes and Strategic Enforcement
Trademark disputes, Oliver says, require the foresight of a chess game.
“It’s not just about reacting to a move — it’s about anticipating the other side’s strategy and knowing when to push forward or negotiate.”
He recalls one case where a startup faced opposition from a multinational company. Through smart strategy and evidence gathering, they not only protected the application but secured a coexistence agreement. The win was not just in registration, it was in protecting future international growth.
IP in a Digital World
With brands increasingly operating across borders and platforms, enforcement is becoming more complex.
“Some countries allow swift enforcement, others are more drawn out. I’d like to see more action around bad faith filings — something similar to the process for the Uniform Domain Name Dispute Resolution Policy (UDRP), which is fast and cost-effective.”
AI and digital tools are also playing an increasing role in monitoring and clearance.
“We use AI-powered tools to monitor trade mark applications and alert clients to potential issues. But there’s still a vital role for human insight and strategic advice.”
Educating and Empowering Clients
Oliver is a strong advocate for IP education—especially for startups and small businesses.
“Often, clients don’t come to us until there’s already a dispute. In my experience, many of these clients don’t fully understand the value of their IP until there is already a dispute or infringement. By that point, they’re on the back foot having to deal with brand damage or even having to rebrand entirely. That’s why I strongly believe that prevention is always better than cure.”
Tidman Legal supports this through blog posts, webinars, and events to raise awareness and simplify complex IP topics.
Looking Ahead: Opportunities and Challenges
What’s next for trademarks?
“AI is accelerating brand creation. But with that speed comes risk — deepfakes, voice cloning, and auto-generated infringing content. It’s a challenging area that may need new legislation to keep pace.”
Oliver also highlights the need for better funding access for early-stage innovators.
“There is support out there, but the hurdles are often high. I’d like to see more funding aimed at startups, which often have limited resources, so they can access professional IP advice early on.”
Personal Reflections
What part of your work do you find most rewarding?
“Helping someone go from an idea sketched on a napkin to a protected brand on shelves or screens is incredibly satisfying. IP is intangible but its impact is very real – when a client sees their brand protected and they can grow with confidence, that’s the real payoff.”
What advice would you give to aspiring IP professionals who are particularly interested in working with trademarks?
“Start by developing commercial awareness as much as legal expertise. Brands live in the real world – they evolve, pivot and rebrand. Also, keep an eye on tech, it’s changing the IP landscape faster than legislation can.”
Beyond the Office
When he’s not helping clients protect their brands, you’ll often find Oliver on the squash court competing in the East of Scotland leagues. A recent highlight? A match against a former world No. 1.
“I only managed to get one point off him but it was a surreal experience!”
Oliver enjoys playing saxophone in his spare time and is also a keen hiker and recommends the Pentland Hills just outside Edinburgh:
“You get an incredible view across the city over to Fife.”
“Playing sax has a lot in common with IP law. In both worlds, timing is everything – whether you’re playing the right rhythm or filing a trademark before someone else does!”
P.S. PatWorld works with companies like Tidman Legal to deliver professional trademark, patent, and registered design searches. You can order a professional search directly through our website—trusted by IP professionals across the UK and beyond. https://patworld.com/us/order-a-search/
When Eric McGill talks about patents, you hear both the scientist’s precision and the strategist’s passion. A seasoned technology transfer expert who has worked with NASA, the FDA, and the U.S. Army, McGill has spent two decades helping inventors and institutions unlock the real-world potential of innovation. His latest venture—Patentelligence—is a bold response to one of IP’s most persistent questions: What is this patent worth, and what should I do with it?
From Lab Bench to Licensing Desk: A Personal Journey into IP
McGill’s path to technology transfer was far from typical. As a grad student working full time and newly married, he invented a product to solve a household issue—sparking his first interaction with the patent system. With help from a university contact, he filed for two patents and ultimately left school to commercialize the invention.
That experience launched a career rooted in both science and business. “It was never just about invention,” he says. “I became obsessed with the question: why do some ideas succeed while others fail?” That question continues to drive his work today.
Patentelligence: A Tool to Answer ‘Now What?’
Inventors and IP managers alike often struggle with what to do after securing a patent. That’s where Patentelligence comes in—an AI-powered patent valuation and decision-support platform that delivers fast, blind, and structured insight into a patent’s market value, commercial potential, and licensing viability.
The platform offers four report types—ranging from quick snapshots to comprehensive 360° briefings—each designed to be affordable, scalable, and tailored to different types of users, including inventors, startup founders, TTOs, and corporate IP teams.
“Our goal,” says McGill, “is to provide clarity at the exact moment people need to decide whether to pursue, pivot, or let go.”
Built with AI, Backed by Expertise
Unlike traditional patent valuation services that rely on time-consuming consulting or raw databases, Patentelligence leverages a blend of agentic AI, automation, and human oversight. It simulates machine learning processes to analyze public data and score a patent’s commercialization likelihood, market valuation band, and licensing income range.
“The system delivers client-ready insights in hours, not weeks,” McGill notes. “It’s not just faster—it’s consistent, repeatable, and grounded in real commercialization logic.”
Disruptive Pricing for an Underserved Market
One of the most transformative aspects of Patentelligence is its pricing. Where traditional reports might cost $5,000–$15,000, Patentelligence’s offerings start at just $97. Reports are usually delivered within one to two days.
“It’s not just about lowering costs,” McGill explains. “It’s about right-sizing insight. Most inventors don’t need a 30-page theory. They need to know: is this worth keeping? Can I license it? What’s a fair range?”
Solving a $6.4 Billion Blind Spot
One major target for Patentelligence is the widespread inefficiency in maintenance fee decision-making. Billions are spent each year to maintain patents—many of which will never generate returns.
McGill saw this problem firsthand early in his career. “At one lab, I was asked to make keep-or-drop decisions on patents—but there was no data to guide me,” he recalls. “It was just judgment.”
That experience inspired Patentelligence’s Maintenance Fee Intelligence Report, which gives data-backed go/no-go recommendations. It’s already proving valuable: university IP offices are beginning to adopt the tool to improve decision-making and reduce wasted spend.
Connecting Tools and Teaching
Patentelligence is one half of McGill’s larger mission. Through his educational platform, The Inventor’s Mentor, he helps inventors navigate the commercialization process and make better licensing decisions.
“Patentelligence is the toolkit,” he says. “The Inventor’s Mentor is the mindset training. Together, they offer inventors both the why and the how.”
Scaling Strategy, Not Just Technology
With a full launch coming soon under Patentelligence.AI, McGill hopes the platform will make IP intelligence more equitable and evidence-based.
“Too many great patents sit idle simply because decision-makers don’t know the next step,” he says. “We’re making that step clearer—and faster—for everyone.”
For McGill, it all comes back to a belief that’s guided him from the start: that smart, well-supported inventors can change the world. And with the right tools, they just might.
Fun Fact: Master of Molecules and Masala
When he’s not evaluating patents or building AI tools, Eric swaps algorithms for aromatics in the kitchen. He’s especially passionate about recreating Indian and Caribbean dishes—so much so that friends have joked he could give local restaurants a run for their money. Cooking, like innovation, feeds his deep curiosity and love of experimentation.
Connect with Eric
To learn more about Patentelligence or connect directly with Eric McGill, reach out via LinkedIn, or visit https://maintenance.enzumosstrategy.com/. His full suite of products will be launching August 2025. To speak to Eric about his work with early-stage inventors and those seeking patent licensing support go to https://www.theinventorsmentor.com/
Whether you’re a solo inventor, a university TTO, or a corporate IP leader, Eric is always open to conversations about smarter, faster paths to innovation.
P.S. Patent valuation is a powerful step in the innovation journey—and it’s even more effective when built on a solid foundation. PatWorld’s professional IP Search services can support innovators at the earliest stages, helping uncover prior art, assess novelty, and evaluate freedom to operate. It’s the ideal complement to the insights provided by Patentelligence. Explore how PatWorld can support your innovation journey: https://patworld.com/us/order-a-search/
If you ask Stephen Mohun how he got into intellectual property, he’ll be the first to admit it wasn’t a lifelong calling. “I’m ashamed to say it was nothing more than a job advert,” he confesses with a laugh. But sometimes the best careers start with curiosity—and in Steve’s case, it sparked a lifelong passion for helping innovators protect and leverage their ideas.
Now the founder of Mohun Aldridge Sykes, Steve has spent nearly four decades advising clients on patents and trademarks, building a reputation for practical, strategic, and empathetic support—especially for those in the manufacturing and engineering sectors. His client base ranges from ambitious start-ups to global corporates, and his advice is always grounded in commercial reality.
“We always start with their bigger goals and work back from there. That’s how we build a real IP strategy—not just a filing plan.”
From Yorkshire Roots to Global Reach
Steve began his career at a local Yorkshire firm and worked his way through larger practices, eventually becoming a partner before founding the firm that became Mohun Aldridge Sykes. Launching his own boutique firm wasn’t just a career pivot—it was a chance to do things his way.
What sets Mohun Aldridge Sykes apart? It’s the depth of relationships. “We genuinely get to know our clients. We’re not just experts on the other end of the phone—we’re part of their strategic team.”
Intellectual Rigor, Commercial Focus
With a background in physics and a mind wired for problem-solving, it’s no surprise Steve is drawn to patent work. “I like understanding how things work,” he says. “Manufacturing clients, especially those in second or third-generation family businesses, are some of my favourites. They’re quietly innovating in ways they don’t always recognise.”
And that’s where Steve sees one of his biggest responsibilities: helping clients see the true value in their ideas. “Too many engineers dismiss their own work as ‘obvious.’ It’s our job to show them that what they’ve created might be valuable—and worthy of protection.”
Helping Clients Navigate Complexity
One of Steve’s great strengths is translating legal complexity into clear, actionable advice. “You have to put yourself in the client’s shoes. Legal jargon just puts up barriers. Our goal is to empower them.”
He’s particularly mindful of budget constraints for early-stage businesses. “The biggest mistake they make is spending too much too soon on the wrong things. We help them build a flexible, strategic IP plan that grows with them.”
A Trusted Partner in Innovation
Steve describes the ideal client relationship as one built on mutual trust. “They need to trust me to give honest, clear advice. And I need to trust that they’re telling me what’s really going on in the business.”
That trust has paid off—whether it’s guiding a manufacturing client into a leadership position through carefully managed IP, or helping a tech start-up secure patents in a notoriously difficult field. “That one surprised even me,” he says, recalling a breakthrough. “But we got there, and today those patents are their most valuable asset.”
Supporting the Next Generation
Mentorship matters to Steve. Mohun Aldridge Sykes welcomes interns and work experience students, giving them a real taste of the profession. “We’ve all had good careers in this field,” he says. “It’s important to put a bit back in.”
Staying Agile in a Changing Landscape
As AI and tech continue to reshape the IP world, Steve stays ahead by listening. “You’ve got to talk to people—clients, colleagues, other professionals—and keep your ear to the ground. The moment you stop adapting, you fall behind.”
His golden rule for entrepreneurs? Talk to your IP attorney early and often. “There’s no such thing as too early, but there’s definitely too late.”
Beyond the Office
When Steve isn’t advising clients or mentoring the next generation, you might find him on stage. A proud member of the Batley Gilbert and Sullivan Society, Steve regularly takes on leading roles—with his recent turn as the captain in H.M.S. Pinafore being a personal highlight. “Both my kids were on stage with me,” he smiles. “There’s nothing better than that.”
Get in Touch with Steve Mohun
With nearly four decades of experience in intellectual property, Stephen Mohun has built a reputation not just for legal precision, but for the kind of clear, trusted advice that clients remember. As founder of Mohun Aldridge Sykes, Steve blends technical expertise with commercial insight—helping innovators protect what matters and make confident decisions along the way.
How PatWorld Supports Firms Like Mohun Aldridge Sykes
At PatWorld, we understand that high-quality, professional patent searches are the foundation of strong IP advice. For firms like Mohun Aldridge Sykes—who focus on strategic guidance, commercial insight, and trusted relationships—our global patent search tools and analyst-led services offer an ideal complement. Whether it’s prior art, freedom-to-operate, or competitive intelligence, we help professionals like Steve deliver peace of mind to their clients with search services they can trust. Click for further information on PatWorld search services.
At the forefront of biotech patenting and innovation sits Ross Cummings, a partner at Gill Jennings & Every LLP (GJE), whose career has been shaped by scientific rigor, a deep commitment to clients, and a passion for future-forward technologies. With a PhD in molecular biology from the London School of Hygiene and Tropical Medicine and nearly two decades of IP experience under his belt, Ross brings a rare fusion of technical depth and commercial strategy to one of the most fast-moving areas in intellectual property: cellular immunotherapy and RNA-based technologies. PatWorld sat down with Ross to discuss recent data relating to cellular immunotherapy, as well as his career journey, strategic insights, and the trends shaping the future of biotech IP.
From the Lab Bench to the Patent Bar
Ross’s journey into the world of patents began during his doctoral work on malaria enzymes. It was then that a Japanese patent, offering unexpected insights into his research, altered the trajectory of his thesis—and eventually his career. “It gave me the tools to push my research forward,” Ross reflects. “That was my first exposure to the value of patents—not just as legal instruments, but as sources of technical knowledge.”
Since then, Ross has become a trusted adviser to biotech innovators, working with companies across the UK, Europe, the US, and Asia. His experience spans everything from gene therapies and diagnostics to CRISPR and synthetic biology.
Navigating the Patent Boom in Cell and Gene Therapies
Ross’s enthusiasm for biotech is palpable, particularly when discussing the renaissance in RNA and cell therapies. “We’re in a period of rapid acceleration,” he says. “COVID-19 changed everything. It proved RNA technologies could be safe, fast, and effective, and that opened the floodgates.”
The data backs this up. Landscape charts generated by PatWorld show a sharp rise in first-priority patent filings over the past decade in cellular immunotherapy—a trend Ross believes is sustainable, provided financing remains strong. “We feel very busy, and that’s usually a good indicator,” he notes.
Figure 1: First Priority Year (see Landscape Charts)
Global Trends and Shifting Hubs
When reviewing Figure 2, which maps first-priority countries, Ross notes the dominant presence of the US in this space. “That’s not surprising—the US biotech scene has much deeper funding,” he comments. “But the UK is punching above its weight, even if some of that activity is driven by a handful of companies.”
He also points to China’s rapidly growing interest in antibodies and biologics. “We’re seeing more biotech filings from China, and companies there are now licensing innovations back to US pharma firms. That’s a shift worth watching.”
Figure 2: 1st Priority Country (see Landscape Charts)
Strategic IP in a Crowded Landscape
For biotech start-ups working in competitive areas like RNA or CAR-T therapies, Ross stresses the importance of early, robust data. “The patent system is shifting—strong experimental support is more important than ever,” he explains.
He also encourages companies to embrace flexibility: “A narrow claim might still be powerful in biotech, especially if it directly protects your approved product. It’s about tailoring your IP strategy to your development path.”
The Human Element in High-Stakes Innovation
Ross is especially motivated by the potential of these therapies to transform lives—particularly for children with rare diseases. “For the first time in history, many of these genetic conditions have real hope,” he says, adding that early screening and fast action can make all the difference.
He also sees platform technologies and adaptable delivery mechanisms as crucial to expanding access to these innovations, both scientifically and commercially.
Looking Ahead: Synthetic Biology and Sustainability
Beyond therapeutics, Ross is enthusiastic about the future of synthetic biology. “We’re approaching a time where we can manufacture materials and chemicals using engineered organisms rather than fossil fuels,” he says. “That has massive implications—not just for IP, but for the planet.”
Inside GJE: Collaboration, Clarity, and Client Focus
Ross describes Gill Jennings & Every as a firm where collaboration and adaptability are central to the culture. “It’s not a siloed environment—we build cross-disciplinary teams to match our clients’ evolving technologies,” he explains. That flexibility is especially valuable in a sector where biotech increasingly intersects with AI, diagnostics, and chemistry.
This approach has helped GJE earn double gold recognition in the IAM Patent 1000 rankings. Ross attributes that success to the firm’s emphasis on clarity, commercial awareness, and strong client relationships. “We focus on practical advice, not just legal precision. We aim to become a real extension of our clients’ teams.”
Beyond the Office
When he’s not helping clients navigate patent law, Ross enjoys life with his young family, reading a mix of sci-fi and science history, and keeping fit. He’s also an advocate of internal knowledge sharing at GJE, from legal updates to seminars on new biotech tools—ensuring both the law and the science stay front of mind.
P.S.PatWorld supports IP professionals like Ross by providing tailored reports that make navigating complex patent landscapes more efficient and informed. Whether it’s freedom-to-operate (FTO) searches, invalidity assessments, or in-depth landscape reports, PatWorld delivers actionable insights across a wide range of technologies. From global trend analysis to highly focused data sets, our support helps attorneys stay ahead of the curve.
The data visualisations referenced in this article were created by Geraint James, Senior IP Manager at PatWorld, using the Questel platform.
From Primary Classrooms to Global Business Leadership
Before becoming the CEO of an international company supporting global workforce compliance, Ann Ellis led a very different kind of team—as a deputy head teacher at a primary school near Halifax. Her journey into international business began in 1995, when her husband John accepted a telecoms role in Italy. The family relocated, and just a year later, Ann co-founded a company to support freelance engineers like John, who were working across Europe but faced complex compliance barriers due to local employment laws.
“I was the first employee of the company,” she recalls. “My office was a broom cupboard in our flat in Northern Italy.”
That modest beginning sparked what would become Mauve Group—a pioneering organization helping businesses to hire, relocate and pay workers around the world compliantly and efficiently. Their breakthrough came with a major telecoms contract in Hungary in 1999, and the company quickly expanded its operations, setting up teams in Cyprus, the UK, and beyond.
Building Mauve Group from the Ground Up
As co-Founder and CEO, Ann played a hands-on role in the company’s early growth. She travelled across continents to set up new entities and build a network of local experts—creating compliant employment solutions for engineers supporting global telecoms networks. That hands-on experience, she says, became the foundation of Mauve’s expertise in global expansion and employment.
What began as a service for telecoms engineers has since evolved into a fully-fledged global Employer of Record (EOR) and compliance consultancy. Mauve now supports clients from a wide range of sectors—including NGOs, universities, and technology companies—enabling them to hire talent across borders without the need for local entities.
Flexible, Compliant Solutions for Global Teams
Today, Mauve Group offers a comprehensive suite of services: EOR, global payroll , immigration support, international HR consultancy, tax compliance, company set-up, and global risk assessments. With entities in 70 countries and solutions in over 150, their global reach is extensive—and personal.
“We’re a flexible company that provides bespoke solutions,” Ann explains. “Our clients vary from large organisations like IMAX to agile tech firms, and we tailor our services to meet their unique needs.”
Ann attributes much of Mauve’s success to its experienced team, many of whom have been with the company for over 15 years. This longevity ensures not just deep institutional knowledge, but trusted relationships with local experts on the ground.
Driving Innovation with Mauve Insight
To meet the demands of modern global employment, Mauve developed its own proprietary platform—Mauve Insight. This tool facilitates seamless onboarding, expense approvals, leave requests, and secure data access. It also offers a Help Center and an automated customer service platform for both clients and workers.
“We’re also building an in-house payroll and invoicing system,” says Ann, “so we can continue to improve our internal operations and provide faster, more efficient services.”
Guiding Clients into New Markets
With clients expanding into diverse markets, Mauve acts as both a guide and a partner. Ann notes that many companies underestimate the complexity of local laws when expanding abroad. Mauve’s risk assessments and local partnerships ensure clients remain fully compliant, avoiding legal pitfalls and unexpected costs.
They’re also developing a market research tool to help businesses identify the most strategic regions for expansion, based on industry trends and compliance factors.
Remote Work and Global Talent Access
The rise of remote work, Ann says, has changed the game. “Companies can now access the best talent regardless of geography,” she notes. “One of our clients in Brazil, a gaming company, hired top professionals across multiple countries. We made it possible for those workers to be employed compliantly, in their local jurisdictions.” This kind of agility, she believes, is key to long-term business growth.
A Personal Touch in Leadership
Despite leading a global operation, Ann stays grounded in the business. “I was a one-woman show in the early days, and I still enjoy getting involved operationally from time to time,” she says. “It helps me understand the challenges different teams face.” Clients often come to Mauve with an idea of how to reach their expansion goal—like setting up an entity—but discover through consultation that EOR might be a more cost-effective and scalable option. Ann and her team are focused on problem-solving and building lasting client relationships.
Work-Life Balance and Global Living
When she’s not running a global business, Ann enjoys connecting with friends and family over good food and wine. With homes in Dubai, Rome, Cyprus, and Miami, she takes full advantage of her love of travel and culture. Regular workouts and scenic walks keep her grounded, while her go-to TV picks include The White Lotus, The Gentlemen, and Slow Horses.
The Mauve Advantage
Under Ann’s leadership, Mauve Group has grown into a trusted partner for organizations navigating the complex world of global employment. By combining local knowledge, regulatory expertise, and a people-first approach, the company empowers clients to grow with confidence.
Connect with Ann Ellis 🔗 Ann Ellis on LinkedIn 🔗 Mauve Group – Mauve Group is a global HR, Employer of Record and business consultancy provider, supporting organisations to expand, hire and pay workers internationally.
How PatWorld Supports Industry Proffesionals Like Ann PatWorld supports IP professionals with expert-led Patent, Trademark, and Design Search services. Whether you’re advising clients on exclusivity strategies, preparing for prosecution or opposition, or managing complex portfolios, our tailored search solutions deliver the clarity and confidence you need to move forward.
From diagnostics to cannabis-based therapeutics, Sophie Topham’s career in biotech patent law has been anything but predictable. A Senior Associate in the biotechnology team at Marks & Clerk, Sophie’s calm, analytical approach is matched by a refreshing curiosity—qualities that have made her an invaluable asset to clients and colleagues alike. We caught up with her to hear about her work, career path, and the rare case that led to one of her most widely read articles.
From Immunology to Innovation
Sophie’s current docket spans a broad range of biotechnology innovations. While she regularly works with immunology-based diagnostics and oncology-related inventions (including peptide vaccines and tools for identifying oncogenic mutations), her work is as diverse as the biotech field itself.
“Over the last few years, I’ve also worked in the cannabis field, particularly with extracts and synthetic cannabinoids for medical uses,” she explains. “And more recently, I’ve seen an increase in devices—some that resemble ELISAs on a chip, others that use antibodies in more novel ways.”
Despite the increasing overlap between biotech and AI, Sophie admits she still has a soft spot for what she calls “pure biology.” “As a biologist by training, those are the ones I find the most intuitive to work with.”
A Curious Case of Prior Art
In 2024, Sophie penned an article about an unusual and educational experience: having a client’s own clinical trial proposal cited as prior art against their European patent. It was the first time she’d encountered such a scenario—and it proved just as useful for the IP community as it did for her personally.
“Opponents in an EPO opposition cited the client’s trial proposal, which we hadn’t seen before due to a team change on the client’s side,” she recalls. “I had to dig into the case law to understand how such documents are interpreted, especially regarding whether the invention was truly disclosed.”
The case raised interesting questions around whether and how other documents—such as scientific publications—can be used to interpret clinical trial proposals, and how that squares with the EPO’s guidelines.
Understanding the Unusual
Sophie is quick to point out that having clinical trial proposals cited as prior art is still uncommon. “Patent applications in biotech typically don’t require clinical data to be granted. In vitro data is often sufficient for meeting plausibility requirements, so most companies file before trials begin,” she says.
Still, her experience highlighted how easy it is for assumptions to trip up even the most diligent teams. “We’ve seen clients express genuine surprise that their own publications can be cited against them—especially in Europe where there’s no grace period.”
The Route Not Taken
Like many in the IP profession, Sophie’s path wasn’t a straight line. “I originally wanted to be an airline pilot,” she laughs. “But when airlines stopped sponsoring training, the cost became unrealistic. Then I remembered a careers talk we had at university about being a patent attorney. I looked into it, and here I am.”
With a background in biological natural sciences from Cambridge, Sophie’s analytical mindset found a perfect home in IP law. She’s since seen applications through from drafting to grant, oppositions, and even appeals.
“Seeing something I’ve written be granted—and knowing I helped a startup gain recognition through their patent—those are the highlights,” she says.
Life Outside the Office
When she’s not deep in a patent claim, Sophie is rarely still. “I always try to move—walk, cycle, yoga, strength training. Even when working from home, I’ll build exercise into my day.” She’s part of a cycling club and makes time for a proper lunch break most days—usually with some kind of movement.
Evenings are more relaxed: cooking from scratch, reading anything from spy novels to translated Japanese fiction, and planning her next getaway. This summer, she’ll finally fulfil a childhood dream—horse riding along the beaches of Morocco with her twin sister.
If Only There Were More Hours…
When asked which fictional invention she’d most like to patent, Sophie doesn’t hesitate: “Hermione Granger’s Time-Turner. I’d love more hours in the day. If I knew how it worked, I’d make one!”
With her blend of sharp legal insight and grounded, genuine enthusiasm for the science behind the patents, Sophie brings a distinct human touch to biotech IP. Whether she’s tackling tricky prior art or galloping down a Moroccan beach, she’s doing it with purpose and passion.
Marks & Clerk is a leading international firm of intellectual property experts, providing comprehensive patent, trade mark, design, and litigation services. With a global presence and deep sector knowledge, Marks & Clerk supports innovative companies from startups to multinationals in protecting and leveraging their IP assets.
How PatWorld Supports Biotech Innovators
At PatWorld, we help biotech companies, attorneys, and researchers access fast, reliable, and intuitive global patent search tools. Our advanced search and analytics features enable professionals like Sophie to:
Patent, Design, and Trademark Research Experts with a combined experience of over 200 years in Intellectual Property searching. Highly trained, dynamic in-house research teams specialising in a wide range of subject matter. All our analysts follow a training program developed by former IPO Examiners. Our teams are available to discuss any specific technical points regarding your search enquiries.
Order a Search Now